Secondary data analysis of universal autism screening in a large primary care network: The impact of early autism screening on age of diagnosis, referral, and entry into intervention (R03)
大型初级保健网络中普遍自闭症筛查的二次数据分析:早期自闭症筛查对诊断年龄、转诊和进入干预的影响 (R03)
基本信息
- 批准号:9762199
- 负责人:
- 金额:$ 8.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-15 至 2020-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcademyAdvisory CommitteesAgeAge-YearsAmericanAwarenessCaringChildChildhoodClinicalCommunitiesConsensusCountryDataData AnalysesData SetDecision TreesDevelopmentDiagnosisDiagnosticEarly DiagnosisEarly InterventionEarly identificationEarly treatmentElectronic Health RecordFamilyFundingFutureGuidelinesHealthcare SystemsIndustry StandardInterventionInterviewJudgmentLeadLogistic RegressionsMedicalOutcomeParentsPediatric HospitalsPediatricsPhiladelphiaPredictive ValuePreventive servicePrimary Health CareProceduresProcessProviderPublishingRandomizedRecording of previous eventsRisk FactorsSamplingScreening ResultSocioeconomic StatusSpecificityTechniquesTestingTimeToddlerUnited StatesVisitagedautism spectrum disorderautistic childrenbaseclassification treescontrol trialdecision tree learningdemographicsevidence baseexperiencefollow-upgroup interventionimprovedmedical specialtiesmeetingspatient populationpediatricianprematurepreventprospectiverandom forestregression treesrural settingscreeningscreening programsecondary analysisstandard of careurban setting
项目摘要
PROJECT SUMMARY/ABSTRACT
The United States Preventive Services Task Force (USPSTF) recently highlighted the lack of studies
examining universal autism screening in primary care and whether it leads to earlier diagnosis and treatment.
This gap prevented them from being able to recommend universal autism screening until there is more
evidence. CHOP has successfully implemented universal autism screening in primary care – 83% screening
compliance in 2016, and has both screening and follow-up primary care available in the electronic health
record. This proposal is for a secondary analysis of this data to directly answer the question of whether
universal screening results in earlier identification and earlier treatment entry for children with autism.
Preliminary analyses on 13,503 children found the sensitivity of the M-CHAT was surprisingly low -- 40%
(specificity 94%, positive predictive value 16%, and negative predictive value of 98%). These results show that,
with only one screen, more children with autism screened negative (n=198) than screened positive (n=128).
This project will include a sample double this size (as more children age into the 4-6 year age range), and
include the wealth of data within the EHR to accomplish two aims. Aim 1 will determine the age of diagnosis
and entry into early intervention for children in a universal autism screening program. Many factors contribute
to the age of diagnosis and intervention, but this dataset can answer three important questions: First, to
determine the age of diagnosis and entry to intervention for children with autism who screened positive as
toddlers at the first v. second screen (“true positives”). Second, to determine the age of diagnosis and early
intervention for children who screened negative but went on to be diagnosed with autism (“false negatives”),
since negative screening results can still lead to heightened awareness of milestones. Third, to explore the age
of diagnosis and intervention for screened v. unscreened children, since a subset of children were not
screened (approximately 17% of well-child visits, as well as some number of children who received sick care
but did not present for well-child visits). Aim 2 will identify factors that would improve screening accuracy, and
then create and validate a clinical decision tree. Pediatricians use clinical judgment to interpret screening
results—this project can provide much needed evidence. Variables such as autism risk factors (e.g., family
history); child demographic, medical, and developmental factors; family variables including socio-economic
status and parent concerns; and practice-level variables including patient population demographics, provider
years of experience, provider compliance with screening, and provider rates of referrals, could inform clinical
judgment. Upon successful completion, this project will contribute the exact type of evidence from universal
screening in primary care requested by the USPSTF, as well as provide guidance for pediatricians on how to
fine tune their interpretation of screening results. This can significantly impact the age of diagnosis and
intervention, by revealing for whom screening is and is not working well.
项目总结/文摘
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Provider Responses to Positive Developmental Screening: Disparities in Referral Practices?
提供商对积极发育筛查的反应:转诊实践中的差异?
- DOI:10.1097/dbp.0000000000000855
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Wallis,KateE;DavisRivera,LaurenB;Guthrie,Whitney;Bennett,AmandaE;Mandell,DavidS;Miller,JudithS
- 通讯作者:Miller,JudithS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JUDITH Susanne MILLER其他文献
JUDITH Susanne MILLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JUDITH Susanne MILLER', 18)}}的其他基金
相似海外基金
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
- 批准号:
0451289 - 财政年份:2005
- 资助金额:
$ 8.6万 - 项目类别:
Standard Grant